
Yuqi Wang
University of Pennsylvania
Yuqi Wang, PhD is a postdoctoral researcher in the Department of Radiology at the University of Pennsylvania. She received her PhD in Electrical and Computer Engineering from Duke University. Her research focuses on developing trustworthy artificial intelligence (AI) algorithms for precision health, with an emphasis on interpretability, uncertainty quantification, and model reliability. Dr Wang has extensive expertise in multi-modal data fusion and medical data analysis, having introduced novel frameworks such as the Concordance-based Predictive Uncertainty (CPU)-Index for lung cancer screening and model-based quality metrics for imaging-clinical data fusion. Her work integrates complex data modelling techniques to advance the development of equitable and transparent AI tools for precision health.

Zhenyu Yang
Duke Kunshan University
Zhenyu Yang, PhD, is a Research Assistant Professor at Duke Kunshan University and Assistant Director of the Jiangsu Provincial Key Laboratory for Smart Diagnosis and Treatment of Lung Cancer. He received his PhD in Medical Physics from Duke University and holds a strong interdisciplinary background that integrates medical physics, computer science, and AI-driven medical imaging. His research focuses on developing robust and trustworthy machine-learning methods for radiotherapy guidance, multi-modal medical image analysis, and cancer early-detection systems. He has led and contributed to multi-centre studies on liver and lung cancer imaging, federated learning frameworks, uncertainty quantification, radiogenomics, and large-scale dataset construction.
This Topical Collection seeks to establish rigorous technical standards for computational models across all domains of medical research and clinical practice. While previous work in medical diagnostics has highlighted both the potential of high-dimensional imaging (CT, MRI, Pathology) alongside low-dimensional clinical factors (genomics, EHR, lab values), these approaches often lead to computationally non-trivial models where over-parameterisation creates “source bias” with pixel-dense data overpowering sparse clinical indicators.
Why is this topic important?
Computational models are increasingly central to modern medicine, spanning diagnostic interpretation, treatment planning, outcome prediction, and therapeutic optimization. However, inconsistent methodological approaches across these domains create barriers to clinical translation, reproducibility, and equitable application. Establishing unified technical standards will accelerate the development of reliable, interpretable models that can be safely deployed across diverse clinical contexts.
What is the aim of the Methods Collection/how will this Methods Collection help the research community?
We propose rigorous technical protocols for developing and validating multimodal computational models in medicine, applicable to diagnostics, treatment planning, prognostic modelling, and therapeutic decision support. These protocols will address equitable data fusion strategies, such as vector grounding schemes, tensor fusion, and attention mechanisms, aiming to prevent any single modality from dominating model decisions. By focusing on fusion methodology rather than specific pathologies or clinical applications, this collection provides a cross-disciplinary toolkit for researchers in oncology, neurology, cardiology and other medical specialities to build robust, interpretable, and clinically actionable computational models.
0 Views
•
2026
•
Chendong Ni1,2, Kun Qian1, Chulong Zhang1, Rihui Zhang3, Shilong Yang4, Zhen Li5, Xiao Luo6, Fuquan Zong6, Juan Yu6, Zebing Liao6
1Medical Physics Graduate Program, Duke Kunshan University, 2Radiotherapy Business Unit, Shanghai United Imaging Healthcare Co., Ltd., 3Wuhan University, 4Shenzhen University, 5ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, 6Department of Radiology, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen Second People's Hospital
Artificial Intelligence Model to Predict PD-L1 Expression in NSCLC
Xiaodan Lin*1
1Institute of Guangzhou Medical University, China